moxifloxacin + ofloxacin

Moxifloxacin + ofloxacin is a combination of two fluoroquinolone antibiotics, moxifloxacin and ofloxacin. Both agents act by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. This dual inhibition leads to rapid bactericidal activity against a broad spectrum of Gram-positive and Gram-negative bacteria. While both drugs are individually approved for various infections such as respiratory tract infections (moxifloxacin) and urinary tract or sexually transmitted infections (ofloxacin), there is no widely recognized or marketed fixed-dose combination product containing both moxifloxacin and ofloxacin together. The rationale for combining these two similar fluoroquinolones in clinical practice is unclear since they share overlapping mechanisms and spectra; typically, combinations involve different classes or add agents like metronidazole to broaden coverage[1][2][3].